Airway inflammation is a characteristic feature in airway diseases such as asthma and chronic obstructive pulmonary disease. Oxidative stress, caused by the excessive production of reactive oxygen species by inflammatory cells like macrophages, eosinophils and neutrophils, is thought to be important in the complex pathogenesis of such airway diseases. The calcium-sensing regulatory protein calmodulin (CaM) binds and regulates different target enzymes and proteins, including calcium channels. In the present study, we investigated whether CaM, via the modulation of calcium channel function, influences [Ca 2 þ ] i in pulmonary inflammatory cells, and consequently, modulates the production of reactive oxygen species by these cells. This was tested with a peptide termed calcium-like peptide 2 (CALP2), which was previously shown to regulate such channels. Specifically, radical production by purified broncho-alveolar lavage cells from guinea-pigs in response to CALP2 was measured. CALP2 was a strong activator of alveolar macrophages. In contrast, CALP2 was only a mild activator of neutrophils and did not induce radical production by eosinophils. The CALP2-induced radical production was mainly intracellular, and was completely blocked by the NADPH-oxidase inhibitor DPI, the superoxide inhibitor SOD and the CaM antagonist W7. Furthermore, the calcium channel blocker lanthanum partly inhibited the cellular activation by CALP2. We conclude that alveolar macrophages, but not neutrophils or eosinophils, can produce extremely high amounts of reactive oxygen species when stimulated via the calcium/CaM pathway. These results may contribute to new therapeutic strategies against oxidative stress in airway diseases.
Airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) are characterized by airway hyper-responsiveness, epithelial damage, oxidative stress and airway inflammation. Inflammatory cells like macrophages, neutrophils, eosinophils and lymphocytes are crucial in the pathogenesis of asthma and COPD. 1, 2 In asthma, the increase in the number of eosinophils correlates in time with the development of bronchial hyperresponsiveness. 3 In COPD, however, the neutrophil appears to be a critical cell, since there are increased numbers of neutrophils in the airways of COPD patients. 4 Moreover, there is evidence that alveolar macrophages also contribute to the development of asthma and COPD. 5, 6 Indeed, macrophages release neutrophil chemotactic factors, which may be the driving force for the inflammatory process in COPD. 6 Furthermore, macrophages produce oxygen radicals, such as superoxide anion (O 2 ÀK ), hydrogen peroxide (H 2 O 2 ), the hydroxyl radical (OH K ) and nitric oxide (NO), which contributes to the pathogenesis of allergic reactions, epithelial cell damage as seen in asthma as well as an oxidant/antioxidant imbalance in COPD. 6 The most predominant radical O 2 ÀK is released during the respiratory burst of granulocytes and macrophages by NADPH-oxidase activity, in response to several stimuli. 7, 8 Superoxide rapidly reacts with NO, yielding the highly reactive oxygen radical peroxynitrite (ONOO À ), which causes tissue injury and induces airway hyperresponsiveness. 9, 10 Interestingly, Calhoun et al 11 have shown that inflammatory cells isolated from the airways of asthmatic patients after allergen challenge release more superoxide than those from control subjects. Calmodulin (CaM), the ubiquitous calcium-sensing regulatory protein, binds and regulates different target proteins, including protein kinases, ion channels and NO synthases. 12 CaM has a structural motif, the EF hand, which binds calcium selectively and with high affinity. 13 The signaling pathways leading to radical production in inflammatory cells include mainly the calcium-dependent phospholipase C-mediated phosphokinase C sequence, although also a variety of protein kinases are also known that are not dependent on the calcium signal. 14 We recently described a 12-mer peptide CALP2 with all characteristics necessary to define the role of CaM in the production of radicals by inflammatory cells. 15, 16 The peptide binds EF hand motifs of the calcium-binding proteins CaM and troponin C. Moreover, we showed that CALP2 inhibited the action of CaM, 15, 17 but increased [Ca 2 þ ] i in airway epithelial cells, the latter being accompanied by an increased NO production by these cells. 18 Moreover, the effects of CALP2 were likely due to the sustained opening of calcium channels present in epithelial cells. 18, 19 In the present study, we used CALP2 to investigate the importance of CaM in radical production. For this purpose, radical production by bronchoalveolar lavage (BAL) cells from guinea-pigs was measured using lucigenin-enhanced chemiluminescence. 20 We found that CALP2 strongly activates alveolar macrophages for radical production. This effect was (1) accompanied by an increase in [Ca 2 þ ] i in these cells and (2) blocked by the CaM antagonist W7. We conclude that alveolar macrophages can produce extremely high amounts of reactive oxygen species when stimulated via the calcium/CaM pathway.
Materials and methods

Design of the Hydropathically Complementary Peptide CALP2
The design of the complementary peptide CALP2 (VKFGVGFKVMVF) was carried out using the computer program AMINOMAT s (Tecnogen ScpA, Verna, Italy), with an averaging window r ¼ 9, a range of inverted hydropathy of 0.8 and also considering eight amino acids of the flanking regions. The program generated 1 417 176 possible sequences, and chose the one with the lowest Qvalue (0.0068). The complementary peptide CALP1 (VAITVLVK) was used as a negative control peptide.
Peptide Synthesis
The peptides were synthesized by using continuous flow solid-phase peptide synthesis with Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry, on a PerSeptive Biosystems 9050 Peptide synthesizer. Preactivated O-pentafluorophenyl ester amino acids with 1-hydroxy-7-azabenzotriazole and preloaded polyethylene glycol graft polystyrene resin were used. The peptides were purified by preparative RP-HPLC. The purity of the products was checked by analytical RP-HPLC. The identity of the peptides was confirmed by TOF-MALDI MS (UAB Core Facility). CALP1 and CALP2 were stored at 41C and dissolved in MilliQ water before each experiment.
Lung Lavages
Broncho-alveolar lavage (BAL) fluids were obtained from male Dunkin Hartley guinea-pigs (Harlan Olac Ltd, Blackthorn, England). Macrophages were derived from BAL fluid from naïve guinea-pigs and para-influenza-3 (PI-3) virus-infected guinea-pigs. For the latter, guinea-pigs were intratracheally inoculated with PI-3 virus (culture infective dose 50 ¼ 10 7.8 /ml) and four days later BAL cells were obtained. 18 Alveolar neutrophils were obtained from guinea-pigs treated with aerosolized LPS (endotoxin, Escherichia coli, 75 mg/ml, Sigma, St Louis, MO, USA) for 30 min. The cells were obtained 24 h after LPS treatment. For eosinophils, guinea-pigs were sensitized by subcutaneous injections with an allergen solution containing 20 mg ovalbumin and 100 mg Al(OH) 3 per ml saline. At 2 weeks after sensitization, the animals were challenged by exposure to aerosolized ovalbumin (0.1% wt/vol in sterile saline). Eosinophils were obtained from the BAL fluid at 24 h after challenge.
For the isolation of BAL cells, the guinea-pigs received a lethal dose of pentobarbitone sodium (Euthesate s 0.6 g/kg body weight, intraperitoneally). The trachea was trimmed free of connective tissue, and a small incision was made for insertion of a cannula into the trachea. The lungs were filled with 10 ml sterile saline of 321C in situ. After gentle lung massage for 1 min, fluid was withdrawn from the lungs and collected in a plastic tube on ice. This procedure was repeated 3 times (total 40 ml) and the cell suspensions recovered from one animal were pooled. The cells was sedimented by centrifugation at 400 g for 10 min at 41C and were washed twice with Krebs-bicarbonate buffer. A sample of the cells was stained with Tü rk's solution and counted in a Bü rker-Tü rk bright-line counting chamber. All cell preparations were analyzed morphologically after centrifugation (45 g for 5 min at room temperature) on microscope slides. Air-dried preparations were fixed and stained with Diff-Quik (Merz þ Dade AG, Dü dingen, Switzerland). The cells were differentiated into alveolar macrophages, eosinophils, lymphocytes and neutrophils by light microscopical observation under oil immersion.
Generation of Chemiluminescence
Radical production was measured by lucigeninenhanced chemiluminescence in a 96-well plate luminometer (Fluoroskan Ascent FL, Labsystems Oy, Helsinki, Finland). Previously, this method was shown to be specific for the detection of superoxide anion. [20] [21] [22] In each experiment, cells from individual animals were used. Cells obtained from one animal were used only once for control and stimulatory radical production (eg control, CALP1, PMA and CALP2; n ¼ 1). Experiments were carried out using four to six different animals (n ¼ 4-6). The concentration of BAL cells from each animal was adjusted to give 10 Â 10 6 cells/ml. The BAL cells were resuspended in Hanks' balanced salt solution (HBSS, Gibco BRL, Breda, The Netherlands). For some experiments, cells were resuspended in calciumfree HBSS (Gibco BRL, Breda, The Netherlands).
To perform experiments on a single cell type (eg macrophages, eosinophils or neutrophils), BAL cells were separated using density-gradient centrifugation over isotonic Percoll (55% v/v, Pharmacia, North Peapack, NJ, USA). After separation, BAL cell suspensions consisted of 98% macrophages, 97% neutrophils and 98% eosinophils, respectively.
Lucigenin was used at a final concentration of 500 mM. Phorbol myristate acetate (PMA, Sigma) was used as a cellular stimulant at final concentrations of 1, 10 or 100 nM (as indicated in the figures) in the reaction mixture. The calcium ionophore ionomycine (Sigma) was used at a final concentration of 10 mM and CALP2 was used in different concentrations as indicated in the figures (final concentrations 0.2-20 mM). The control peptide CALP1 was used in a final concentration of 10 mM. The superoxide dismutase inhibitor superoxide dismutase polyethylene glycol (PEG-SOD, Sigma) (IC 50 ¼ 50 U/ml), 23 30 were used as inhibitors at final concentrations of 100 U/ml, 10, 50, 10 and 75 mM, respectively.
The final volume in each well was 250 ml. The broncho-alveolar cells (100 ml) were stimulated with: (A) control solution (HBSS), (B) 25 ml CALP1 ( ¼ control peptide), (C) 25 ml ionomycin, (D) 25 ml PMA or (E) 25 ml CALP2. When inhibitors were used, cells were incubated with 25 ml of this inhibitor 10 min before stimulators were added.
Chemiluminescence was measured every 2 min for 60 min at 371C. The integrated response was determined with a computer program supplied with the luminometer. Data are presented as the total chemiluminescence production during 60 min (area under the curve (relative light units (RLU) * 60 min)).
Similar experiments were performed on human blood neutrophils (10 Â 10 6 cells/ml). Therefore, neutrophils were isolated from venous blood of healthy volunteers (Bloedbank Midden-Nederland, Utrecht, The Netherlands) as described previously by Verbrugh et al. 31 After every experiment, the viability of the cells was assessed by the Trypan blue extrusion test. No effect of any of the chemicals on cell viability was observed (data not shown).
Measurement of Superoxide Production by Alveolar Macrophages
Superoxide production was determined by a kinetic assay of the superoxide dismutase-inhibitable reduction of ferricytochrome c. 32 Therefore, freshly isolated alveolar macrophages from guinea-pigs were resuspended in HBSS (10 Â 10 6 cells/ml). Ferricytochrome c was used at a final concentration of 100 mM. PMA and CALP2 were used at final concentrations of 0.1 and 20 mM in the reaction mixture, respectively. SOD was used as an inhibitor at a final concentration of 100 U/ml. The final volume in each well was 250 ml. The bronchoalveolar cells (100 ml) were stimulated with: (A) control solution (HBSS), (B) 25 ml PMA or (C) 25 ml CALP2. When SOD was used, cells were incubated with 25 ml of SOD for 10 min before stimulators were added. The optical density was read at 550 nm at 371C during 60 min, using a Benchmark microplate reader (Bio-Rad Laboratories, Hercules, CA, USA). Data are presented as the maximum response obtained during 60 min.
Measurement of Calcium in Alveolar Macrophages
Freshly isolated alveolar macrophages from guinea pigs were resuspended in HBSS added with 0.1 mM HEPES (Gibco BRL), 0.1% fetal calf serum (FCS) and 2.5 mM probenicid (Sigma). The cells were loaded with 4 mM fura 2-AM at room temperature for 1 h in the dark. Thereafter, the cells were washed 3 times and resuspended at a final concentration of 10 Â 10 6 cells/ml in HBSS. For some experiments, cells were washed and resuspended in calcium-free HBSS. Cells were allowed to de-esterify for 30 min before they were used. Cells were placed in a 96-well plate at a concentration of 1 Â 10 6 cells/well. The cells were stimulated with control solution, CALP1 (10 mM), PMA (0.1 mM) or CALP2 (20 mM) and fluorescence of Fura 2, alternately excited at 340 and 380 nm with 5 s interval, was monitored at 510 nm using a Fluoroskan Ascent FL (Labsystems Oy, Helsinki, Finland). The ratio of the two images (F 340 /F 380 ) was determined. The maximum and minimum fluorescence intensities were obtained with 0.1% Triton X-100 and 10 mM EGTA in 2 M Tris-HCl, pH 8.5, respectively.
Statistical Analysis
Differences in chemiluminescence production due to agonist stimulation was tested using the Student's t-test (unpaired). When the effect of inhibitors was tested, data were statistically analyzed using ANO-VA followed by post-hoc pair wise comparison of the effects of the inhibitor compared to control levels. All P-values o0.05 were considered to reflect a statistically significant difference.
Results
Effect of Ionomycin, PMA and CALP2 on Chemiluminescence Production by Alveolar Macrophages
Lucigenin-enhanced chemiluminescence production was used to investigate the effects of ionomycin, PMA and CALP2 on reactive oxygen species production by alveolar macrophages. Therefore, BAL cells from naive guinea-pigs were used, which consist of 88% macrophages ( Figure 1 ). Typical tracings of chemiluminescence production by alveolar macrophages after stimulation with ionomycin, PMA or CALP2 are shown in Figure 2 . Basal chemiluminescence production during 60 min by macrophages was 490747 RLU (Figure 3 ). The calcium ionophore ionomycin increased the basal response to 7487119 RLU (Po0.05). The chemiluminescence production was increased only briefly after application of the ionophore (Figure 2, inset) ; this explains the slight increase in production during 60 min (Figure 3 ). PMA dose-dependently increased radical production to 918728 RLU.
CALP2 also dose-dependently increased the production of radicals (Po0.001). However, CALP2 was a five times more effective inducer than PMA, since the RLU was increased to 4958765 at the highest CALP2 concentration (Figure 3) . Also, CALP2 (20 mM) stimulated radical production in calciumfree medium (4067771 RLU). However, in this medium there was a different kinetic profile with an initial high increase in radical production, which stopped after 30 min of stimulation ( Figure 2 ). The negative control peptide CALP1 had no effect on chemiluminescence ( Figure 3 ). in calcium-free medium. Chemiluminescence production is expressed as RLU. Ionomycin and CALP2 increased radical production shortly after application, whereas PMA-stimulated production started 20 min after application. Figure 3 Chemiluminescence production by macrophages upon stimulation with control solution (white bar), the control peptide CALP1 (10 mM, light-gray bar), ionomycin (10 mM, dotted bar), increasing concentrations of PMA (hatched bars) and CALP2 (black bars) and CALP2 (20 mM) in calcium-free medium (darkgray bar). Chemiluminescence production is expressed as the area under the curve (RLU Â 60 min, mean7s.e.m., n ¼ 4). PMA and CALP2 dose-dependently increased radical production by macrophages. CALP2 also increased radical production in calcium-free medium. *Po0.05, ***Po0.001, Student's unpaired t-test compared to control.
CALP2-induced Radical Production is Mainly Intracellular and is Blocked by PEG-SOD and DPI
To investigate which radical is mainly produced by alveolar macrophages after stimulation with CALP2, we performed experiments in the presence of the membrane-permeable PEG-SOD. It was found that the response to both PMA and CALP2 could be completely inhibited by PEG-SOD (Po0.001; Figure 4a ). Moreover, the PMA-and CALP2-induced radical production could be completely blocked by the NADPH-oxidase inhibitor DPI (Figure 4b ). We further investigated whether CALP2-induced superoxide production is intracellular or extracellular. For this purpose, we used the superoxide dismutase-inhibitable reduction of ferricytochrome c, which only detects extracellular superoxide production. 32 The activation of alveolar macrophages with PMA resulted in extracellular radical production, which could be inhibited by SOD ( Figure 5 ).
Interestingly, CALP2-induced radical production was mainly intracellular, since no reduction of ferricytochrome c could be observed after CALP2 stimulation ( Figure 5 ).
These results show that CALP2 is a very potent activator of alveolar macrophages of guinea-pigs and that superoxide anion, released intracellularly by NADPH-oxidase, is the main oxygen radical produced by CALP2 stimulation.
Effect of PMA and CALP2 on Chemiluminescence Production by Alveolar Neutrophils
Next it was investigated as to whether CALP2 also stimulates alveolar neutrophils. Therefore, BAL cells from LPS-treated guinea-pigs were used, which consists of 40% macrophages and 56% neutrophils (Figure 1 ). Neutrophils were sepaqrated using a Percoll density gradient. Basal chemiluminescence production by neutrophils was 127728 RLU (Figure 6a) . PMA increased the radical production to 28177334 RLU (Po0.001). CALP2 only slightly increased the production of radicals by neutrophils to 8277156 (Po0.01; Figure 6a) . Again, the negative control peptide CALP1 had no effect on chemiluminescence production (Figure 6a ). In the presence of the membrane-permeable PEG-SOD, the response of alveolar neutrophils to both PMA and CALP2 could be completely inhibited (Po0.001; Figure 6a ). Similar results were found with unstimulated neutrophils isolated from human blood (Figure 7) , indicating that primed neutrophils have effects similar to PMA and CALP2 compared to resident cells. 
Effect of PMA and CALP2 on Chemiluminescence Production by Alveolar Eosinophils
To investigate the effect of CALP2 on radical production by alveolar eosinophils, BAL cells from ovalbumin sensitized and challenged guinea-pigs were used. This cell population contains 48% macrophages and 46% eosinophils (Figure 1 ). Eosinophils were separated using a Percoll density gradient. Basal chemiluminescence production by eosinophils was 70777 RLU (Figure 6b) . PMA increased the radical production to 52657187 RLU (Po0.001). CALP2 had no effect on the radical production by alveolar eosinophils (733750 RLU; Figure 6b ). The negative control peptide CALP1 had no effect on chemiluminescence production either (Figure 6b ). In the presence of PEG-SOD, the response of alveolar eosinophils to PMA could be completely inhibited (Po0.001; Figure 6b ).
Effect of CALP2 on Chemiluminescence Production by Primed Macrophages
Since in the previous experiments preactivated neutrophils and eosinophils were used, we also primed alveolar macrophages to investigate whether CALP2 responses are different between naive macrophages and preactivated macrophages. For this purpose, we used alveolar macrophages obtained from PI-3 virus-infected guinea-pigs (Figure 1 ). These cells show greater responses to PMA (Figure 8) , indicating an activated state of the macrophages. 33 As shown in Figure 8 , no difference in the CALP2 response was observed between naive macrophages and primed macrophages from PI-3 virus-infected guinea-pigs. Together with the results obtained from isolated unstimulated blood neutrophils (Figure 7 ), these findings again show that the priming of alveolar cells does not alter the response to CALP2.
CALP2 Increases [Ca 2 þ ] i in Alveolar Macrophages
Previously, we showed that CALP2 blocks the action of the calcium-regulatory protein CaM. 15 Interestingly, this resulted in an increase of [Ca 2 þ ] i . 18 Therefore, we hypothesized that the action of CALP2 on superoxide production by alveolar macrophages is due to the inhibition of CaM activation and therefore an increase of [Ca 2 þ ] i in these cells. The basal fluorescence ratio (F 340 /F 380 ) in alveolar macrophages was 1.8570.01 ( Figure 9 ). PMA stimulation only slightly increased F 340 /F 380 (2.4570.01, Po0.001). CALP2, however, increased F 340 /F 380 in macrophages to 4.2170.05 (Po0.001; Figure 9 ). The negative control peptide CALP1 had no effect on F 340 /F 380 . In calcium-free medium, CALP2 slightly, but significantly, increased F 340 / F 380 (Po0.05; Figure 9 ). The increase in F 340 /F 380 was 50% of the total release from intracellular stores as measured by the administration of the Ca 2 þ -ATPase inhibitor thapsigargin (data not shown). From this, we conclude that CALP2 increases [Ca 2 þ ] i in alveolar macrophages due to both release from intracellular stores and influx of extracellular calcium.
Inhibition of the CALP2-induced Radical Production by W7, 2-APB and Lanthanum
To investigate the hypothesis that radical production by CALP2 is due to modulation of activation of CaM, chemiluminescence experiments were performed on alveolar macrophages in the presence of the CaM antagonist W7. Basal chemiluminescence production was 587748 RLU (Figure 10a) , which was Figure 6 Chemiluminescence production by isolated alveolar (a) neutrophils and (b) eosinophils upon stimulation with control solution (white bar), the control peptide CALP1 (10 mM, gray bar), PMA (0.1 mM, hatched bar) and CALP2 (20 mM, black bar). PEG-SOD completely inhibited the oxygen radical production by both alveolar neutrophils (a) and eosinophils (b) after stimulation with PMA and CALP2. Chemiluminescence production is expressed as RLU Â 60 min (mean7s.e.m., n ¼ 4). PMA highly and CALP2 slightly increased radical production by neutrophils. Radical production by eosinophils was increased after stimulation with PMA, but CALP2 had no effect on this production. **Po0.01, ***Po0.001, ANOVA compared to control. ### Po0.001, ANOVA compared to respective stimulus without inhibitor. Figure 7 Chemiluminescence production by isolated human blood neutrophils. Cells were stimulated with control solution (white bar), the control peptide CALP1 (10 mM, gray bar), PMA (0.1 mM, hatched bar) and CALP2 (20 mM, black bar). Chemiluminescence production is expressed as RLU Â 60 min (mean7s.e.m., n ¼ 6). PEG-SOD completely inhibited the oxygen radical production by human blood neutrophils after stimulation with PMA and CALP2. ***Po0.001, ANOVA compared to control. ### Po0.001, ANOVA compared to respective stimulus without inhibitor.
partly inhibited by W7 (110711 RLU, Po0.001). Moreover, W7 completely inhibited CALP2-induced chemiluminescence production by macrophages (40727205 RLU for CALP2 and 171717 RLU for W7 þ CALP2, Po0.001; Figure 10a ). To further explore the effects of CALP2, we performed experiments in the presence of the IP 3 -receptor antagonist 2-APB and the calcium channel (I CRAC ) blocker lanthanum. Both 2-APB (26%, Po0.05) and lanthanum (18%, Po0.001) partly inhibited the effects of CALP2 (Figure 10b and c, respectively) . From this, we conclude that CaM is crucial for the production of reactive oxygen species by CALP2 in alveolar macrophages.
Discussion
Research on the role of reactive oxygen species in several inflammatory diseases, especially asthma and COPD, may provide new insights into the pathogenesis of these diseases. Neutrophils and macrophages are likely to play key roles in the development of COPD, 2 whereas eosinophils are the predominant cells involved in the pathogenesis of Figure 8 Chemiluminescence production by alveolar macrophages from naive control animals (N) and PI-3 virus-infected guinea-pigs (P). Cells were stimulated with control solution (white bars), the control peptide CALP1 (10 mM, gray bars), PMA (0.1 mM, hatched bars) and CALP2 (20 mM, black bars). Chemiluminescence production is expressed as RLU Â 60 min (mean7 s.e.m., n ¼ 6). Radical production in PI-3 virus treated animals was slightly increased after stimulation with PMA. No difference in CALP2-induced radical production by macrophages was found between control animals and PI-3-infected animals. *Po0.01, Student's unpaired t-test compared to respective naïve control. asthma. The exact role for the alveolar macrophage in asthma seems to be complex, since some researchers postulate the involvement of macrophages and their products, whereas others do not. 1, 5, 11, [34] [35] [36] The inflammatory cells generate reactive oxygen species that might be crucial in airway inflammation. Although their production is increased in asthma and COPD, 11, 37 the exact role of reactive oxygen species is not fully understood. The late airway response in asthma is characterized by the appearance of high-density alveolar macrophages with potentiated superoxide release.
11 Also, macrophages have a primary role in regulating the inflammatory response and tissue destruction in COPD. 6 These macrophages release chemotactic factors, leading to increased neutrophils in the airways of COPD patients. 4 Evidence from The European Network For Understanding Mechanisms of Severe Asthma (ENFUMOSA) project suggests that neutrophils contribute to airflow obstruction and epithelial damage in asthma. 38 Reactive oxygen species induce oxidative stress and oxygen metabolites contribute to epithelial damage and consequently airway hyper-responsiveness, which are characteristic features of asthma. 39, 40 Furthermore, oxidative processes have a fundamental role in patients with COPD, since they increase NF-kB activation, which in turn leads to the release of inflammatory mediators such as interleukin-8, interleukin-1 and tumor necrosis factor a. 41 Moreover, increasing evidence suggests roles for oxygen radicals in intracellular signaling and as inducers of apoptosis. 42, 43 Inhibition of the respiratory burst by macrophages (and other inflammatory cells) may therefore be a useful target for new therapeutic targets for asthma and COPD. 41, 44 Furthermore, knowing the exact mechanisms by which inflammatory cells produce reactive oxygen species may be even more important.
In 1984, it was shown that radical production by macrophages is due to a rise in [Ca 2 þ ] i . 45 The source for the increase in [Ca 2 þ ] i was mainly extracellular calcium. In the present study, we showed that the calcium-regulatory protein CaM is essential in radical production by alveolar macrophages. To address this issue, the selective CaM inhibitor CALP2 15 was used, and we found that CALP2 is a very potent activator of macrophages. Interestingly, we have shown that CALP2 only slightly activates neutrophils, whereas eosinophils were not activated at all. Although macrophages were obtained from naïve guinea-pigs and neutrophils and eosinophils were obtained after exposure of the airways to inflammatory stimuli, several data support our hypothesis that the altered responses to CALP2 are not due to different activation states of the cells. First, all used cell types still responded to PMA. Second, alveolar macrophages activated in vivo with PI-3 virus, 33, [46] [47] [48] showed the same response to CALP2 compared to naïve macrophages. Third, responses to CALP2 of isolated unstimulated blood neutrophils were comparable with responses of lung neutrophils obtained after LPS exposure.
We have shown that the CALP2-induced radical production was five times larger than that of the PKC stimulator PMA. Interestingly, CALP2-induced radical production was mainly intracellular, whereas PMA-induced radical production was, at least partly, extracellular. Since CALP2-induced chemiluminescence production was much higher (six times) than that of the phagocytotic compound zymosan, we can exclude the possibility that the radical production by CALP2 is due to phagocytosis by macrophages. Furthermore, CALP2 increased [Ca 2 þ ] i in these cells. The cell-permeable PEG-SOD, 49 completely inhibited the response of CALP2. Therefore, intracellular superoxide seems to be the main radical produced by CALP2 stimulation.
The NADPH-oxidase system constitutes the primary defense mechanism against microbial infections. The superoxide release is mainly produced extracellularly; this may also cause severe tissue damage and induce inflammatory responses in asthma and COPD. Since the radical production by CALP2 was mainly intracellular, it is likely that the CALP2-induced superoxide production is involved in cellular signaling processes, but not tissue damaging. 50 The role of reactive oxygen species in cell signaling includes a rapid increase in [Ca 2 þ ] i in the cytoplasm of diverse cell types, 51 which might lead to apoptosis. 52 This increase is both due to calcium release from stores and extracellular calcium influx. Moreover, the increase in [Ca 2 þ ] i subsequently leads to a further activation of several enzymes involved in radical production, including NOS and NADPH-oxidase, resulting in a sustained increase in radical production. We therefore postulate that CALP2, directly or indirectly, activates CaM, which results in intracellular radical production, which subsequently increases [Ca 2 þ ] i , leading to a further increase in radical production. In addition, CALP2 might inhibit the negative feedback mechanism involved in calcium channel functioning described hereafter, and in this way modulate calcium-and radical responses in the cell.
Previously, we showed that CALP2 also increases [Ca 2 þ ] i and nitric oxide production in airway epithelial cells. 18 It was hypothesized that CALP2, as a CaM antagonist, opens calcium channels in airway epithelial cells, leading to calcium influx in these cells. 18, 53, 54 Therefore, we now postulate that the production of radicals by CALP2 in macrophages is predominantly due to an increase of [Ca 2 þ ] i . Although less than in the presence of extracellular calcium, we found that macrophages still produce radicals upon stimulation with CALP2 in calcium-free medium. This production was accompanied by a much smaller increase in [Ca 2 þ ] i than seen in the presence of extracellular calcium. Therefore, extracellular calcium indeed plays a role in the effect of CALP2 on radical production in alveolar macrophages, but certainly is not the only contributor. Since CALP2 increased [Ca 2 þ ] i in the absence of extracellular calcium, CALP2 also stimulates calcium release from intracellular stores. The typical tracings of CALP2-induced radical production show that in calcium-free medium there is a large, temporary increase in radical production, whereas in the presence of extracellular calcium the radical production is more sustained. This could mean that first CALP2 releases calcium from intracellular stores, leading to the initial high radical production. Secondly, CALP2 opens storeoperated calcium channels, which results in a further increase in [Ca 2 þ ] i , with the consequent more sustained production of radicals. 18 The higher initial radical production after CALP2 stimulation in calcium-free medium is possibly due to a different kinetic profile of [Ca 2 þ ] i under these conditions, leading to altered regulatory (feedback) mechanisms.
The combination of both intracellular calcium release and influx of extracellular calcium through store-operated channels results in the sustained radical production in alveolar macrophages. 55 This hypothesis is confirmed by the fact that lanthanum, a selective inhibitor of store-operated calcium channels (I CRAC ), 56 but not voltage-dependent calcium channel blockers like nifedipine or verapamil (data not shown), inhibited the action of CALP2. Furthermore, I CRAC channels are present in macrophages and neutrophils but not in eosinophils 57, 58 Since CALP2 did not activate eosinophils, this further strengthens the hypothesis that CALP2, at least partly, acts via (store-operated) calcium channels. Furthermore, the IP 3 -receptor antagonist 2-APB 30 also partly inhibited the effect of CALP2. Hirota et al 59 showed that binding of CaM to the IP 3 R1 receptor inhibits IP 3 R channel activity in a calcium-dependent manner. Furthermore, Zhang et al 60 recently showed that inhibition of the inhibitory action of CaM is a key step in the activation of Drosophila Trp channels by IP3Rs. Taken together, these results suggest that CALP2 increases radical production by macrophages through inhibition of CaM, located in different parts of the cell.
As mentioned before, CALP2 increases NO production by airway epithelial cells, due to an increase of [Ca 2 þ ] i in epithelial cells and the consequent activation of the calcium/CaM-dependent constitutive nitric oxide synthase (cNOS). 18 Since superoxide is also generated by different NOS isotypes, 61 it is possible that CALP2 stimulates NOS in alveolar macrophages, leading to radical production. 10 However, CALP2-induced increase in chemiluminescence was not inhibited by the NOS inhibitor L-NAME (data not shown). We have shown that the CALP2-induced responses in macrophages can be inhibited by the NADPH-oxidase inhibitor DPI. 62 Therefore, it seems likely that the NAPDH-oxidase, present in macrophages and neutrophils, 63 Although CALP2 itself is an inhibitor of CaM, the CaM inhibitor W7 completely blocked the effects of CALP2. First, this can be explained by a direct effect of W7 on NADPH oxidase. In this case, W7 blocks the CALP2-induced radical production by inhibiting the effect of CALP2-released calcium on NADPH oxidase. Second, W7 can inhibit the CALP2-induced increase in [Ca 2 þ ] i through blockage of the effects of CALP2 on store-operated calcium channels. Since CALP2 has an inverted hydropathic profile to CaM, it seems unlikely that W7 binds directly to CALP2 and therefore blocks the effect of CALP2. Furthermore, we earlier showed that CALP2 did not bind to CaM in the hydrophobic core, which is typical for W7, 66 but rather interferes with the carboxyl-terminal calcium binding site of CaM. 15 Moreover, it was recently shown that, depending on the protein bound to CaM, CaM undergoes marked different conformational changes, leading to changed calcium-binding. 67 It is therefore assumed that W7 inhibits the action of CALP2 through a different inhibitory mechanism on CaM, leading to altered conformational changes.
A role for CaM in the activation of different cell types has been previously shown. The CaM antagonist W7 inhibited PAF-induced superoxide production by macrophages 68 and calcium ionophore-triggered generation of superoxide by macrophages was dose-dependently inhibited by the CaM antagonist fluphenazine 69 Interestingly, extracellular calcium had a predominant influence on the production of superoxide and nitric oxide in macrophages 70 We show that, besides the influx of extracellular calcium, release from intracellular stores also plays a role in radical production. Although inhibition of radical production by CaM antagonist has been described earlier, 64, 69, 71 we show that the combination of calcium/CaM is necessary for activation and, more importantly, calcium/CaM regulates activation to a different degree in certain cell types. Moreover, inhibition of radical production by CaM antagonists is dependent on the site of action on CaM, since the effect of CALP2 was blocked by W7.
We recently used CALP1 and CALP2 to investigate the role for CaM in the development of asthmatic features after ovalbumin challenge in an allergic asthma model in guinea-pigs. 72 We found that specific modulation of CaM activity by CALP1 prevents the development of allergen-induced airway hyper-responsiveness, a key feature of asthma. Moreover, CALP1 inhibited PMA-induced radical production by BAL cells from ovalbumin-challenged animals. However, specific modulation of CaM activity by CALP2 had no influence on these asthmatic features. We postulated that the effects of CALP1 on airway hyper-responsiveness were due to the decreased radical production by alveolar macrophages in ovalbumin-sensitized and -challenged animals. In contrast, CALP2 has no effect on airway hyper-responsiveness, which is most likely due to an increased radical production by macrophages, leading to unaltered asthmatic features. Together, based on the current finding that CALP1 and CALP2 specifically act on alveolar macrophages, we postulate an important role for CaM in these cells for the development of asthmatic features. Alveolar macrophages may contribute to the development of asthma, since they produce numerous mediators including cytokines, growth factors, ROS and arachidonic acid derivatives. 6 ROS increases airway smooth muscle contraction either directly 73 or indirectly by influencing the reactivity of the airways to contractile and relaxing agonists. 74 Moreover, they are involved in the development of airway hyper-responsiveness. 50, 75 Furthermore, ROS has several effects on other cells and structures involved in the pathology of asthma, such as blood vessels, nerves, epithelial-and inflammatory cells.
In conclusion, we found that the specific CaM modulator CALP2 is (1) a strong activator of alveolar macrophages, (2) a mild activator of alveolar neutrophils and (3) is unable to activate alveolar eosinophils. Since CALP2 is a selective CaM antagonist, the present study provides evidence that CaM regulates the production of reactive oxygen species by alveolar macrophages. Further, the calcium-binding site of CaM is likely to have stimulatory effects, whereas the hydrophobic core of CaM has inhibitory effects on radical production. Elucidation of the exact role of CaM in radical production may contribute to the development of new therapeutic strategies for the treatment of inflammatory diseases.
